1         Introduction
1.1  Objective
1.2  Market Introduction
1.3  Market Scope
1.4  Methodology
1.5  Scenario based Forecast
1.6  Who will benefit from this report?
1.6.1        Business Leaders & Business Developers
1.6.2        Vaccines Professionals
1.6.3        Policy Makers, Budget Planners and Decision Makers
1.6.4        Civil Government Leaders & Planners
1.6.5        Financial analysts, Investors, Consultants
1.7  Language

2         Executive Summary
2.1  Vaccines Market Trends and Insights
2.2  Top Five Major Findings
2.3  Major Conclusion
2.4  Important Tables and Graphs

3         Current Market Overview of Global Vaccines Market
3.1  Market Overview
3.2  A Brief History of Vaccination
3.3  Defense Mechanism of Vaccine
3.4  Classification of Vaccines
3.4.1        Live Attenuated Vaccines
3.4.2        Inactivated Vaccines
3.5  Composition of Vaccines
3.6  Vaccine Preventable Diseases

4         Current Market Trends of the Global Vaccines Market
4.1  Stages of Vaccine Development, Testing, and Regulation
4.1.1        Exploratory Stage
4.1.2        Pre-Clinical Stage
4.1.3        Clinical Development
4.1.4        Vaccine Post-Licensure Monitoring
4.1.5        Manufacturing
4.2  Stakeholders in Vaccine Development
4.3  Vaccine Implementation Options
4.3.1        Implementation and Immunization in the US
4.3.2        Implementation and Immunization in Europe
4.3.3        Implementation and Immunization in Asia-Pacific Region
4.4  COVID 19 Vaccine
4.4.1        Vaccine Production
4.4.2        Technology Platforms
4.4.3        Vaccine Candidates
4.4.4        Partnerships

5         Market Technologies
5.1  Reverse Vaccinology
5.2  Structural Vaccinology
5.3  Immunoprophylaxis by gene transfer
5.4  Prefilled AD Injection Devices
5.5  Needle-free vaccine delivery
5.6  Nanopatch Technology
5.7  Ready-to-use Inactivated Vaccines
5.8  Mucosal Vaccination
5.9  Synthetic Antigen Vaccines
5.10      DNA Vaccines

6         Market Dynamics
6.1  Drivers
6.1.1        Increased incidence of infectious diseases
6.1.2        Government Support in Vaccine Development
6.1.3        Enhanced Vaccine R&D
6.1.4        COVID 19 | Impact on Vaccine Market
6.2  Restraints
6.2.1        Huge Capital Investments with the Vaccine Development
6.2.2        Longer timeline required for vaccine development
6.3  Challenges
6.3.1        Supply chain challenges in temperature-controlled vaccines
6.3.2        Social and Political Negligence
6.3.3        Vaccine Hesitancy
6.3.4        Lack of Vaccine Development Knowledge & Infrastructure
6.4  PEST
6.4.1        Political
6.4.2        Economic
6.4.3        Social
6.4.4        Technology
6.5  Porter’s Five Forces
6.5.1        Buyer’s Bargaining Power
6.5.2        Suppliers Bargaining Power
6.5.3        Threat of New Entrants
6.5.4        Threat of Substitutes
6.5.5        Rivalry among Competitors

7         Country Analysis
7.1  United States of America (USA)
7.1.1        Introduction
7.1.2        Healthcare Sector
7.1.3        Vaccination coverage in US
7.2  Canada
7.2.1        Introduction
7.2.2        Healthcare Sector
7.2.3        Vaccination Coverage in Canada
7.3  France
7.3.1        Introduction
7.3.2        Healthcare Sector
7.3.3        Vaccination coverage in France
7.4  United Kingdom (UK)
7.4.1        Introduction
7.4.2        Healthcare Sector
7.4.3        Vaccination coverage in United Kingdom
7.5  Italy
7.5.1        Introduction
7.5.2        Healthcare Sector
7.5.3        Vaccination coverage in Italy
7.6  Germany
7.6.1        Introduction
7.6.2        Healthcare Sector
7.6.3        Vaccination coverage in Germany
7.7  Australia
7.7.1        Introduction
7.7.2        Healthcare Sector
7.7.3        Vaccination coverage in Australia
7.8  India
7.8.1        Introduction
7.8.2        Healthcare Sector
7.8.3        Vaccination coverage in India
7.9  Egypt
7.9.1        Introduction
7.9.2        Healthcare Sector
7.9.3        Vaccination coverage in Egypt
7.10      South Africa
7.10.1     Introduction
7.10.2     Healthcare Sector
7.10.3     Vaccination coverage in South Africa

8         Global Vaccines Market Forecast by Region to 2028
8.1  Total Global Market by Region to 2028
8.2  Total Global Vaccines Market by Region (By Disease Indication) to 2028
8.2.1        North America
8.2.2        Europe
8.2.3        APAC
8.2.4        Middle East
8.2.5        LATAM
8.2.6        Rest of the World
8.3  Total Global Market by Region (By Patient Type) to 2028
8.3.1        North America
8.3.2        Europe
8.3.3        APAC
8.3.4        Middle East
8.3.5        LATAM
8.3.6        Rest of the World

9         Global Vaccines Market Forecast by Technology to 2028
9.1  Total Global Market by Technology to 2028
9.2  Total Global Market by Technology (By Type) to 2028
9.2.1        Conjugate Vaccines
9.2.2        Inactivated and subunit Vaccines
9.2.3        Live attenuated Vaccines
9.2.4        Recombinant Vaccines
9.2.5        Toxoid Vaccines
9.3  Total Global Market by Technology (By Mode of Administration) to 2028
9.3.1        Conjugate Vaccines
9.3.2        Inactivated and subunit Vaccines
9.3.3        Live attenuated Vaccines
9.3.4        Recombinant Vaccines
9.3.5        Toxoid Vaccines

10     Global Vaccines Market Forecast by Patient Type to 2028
10.1      Total Global Vaccines Market by Patient Type to 2028
10.2      Total Global Vaccines Market by Patient Type (By Technology) to 2028
10.2.1     Pediatric patients
10.2.2     Adult patients
10.3      Total Global Vaccines Market by Patient Type (By Mode of Administration) to 2028
10.3.1     Pediatric patients
10.3.2     Adult patients

11     Corona Impact on Vaccines Market
11.1      Introduction
11.2      Corona Scenario-1
11.3      Corona Scenario-2
11.4      Corona Scenario- 3

12     Scenario Analysis
12.1      Introduction
12.2      Scenario Analysis 1
12.3      Scenario Analysis 2

13     Opportunity Analysis
13.1      By Region
13.2      By Technology
13.3      By Patient Type

14     Company Profiling
14.1      Pfizer
14.1.1     Company Profile
14.1.2     Products & Services
14.1.3     Segment Revenue
14.1.4     Financial info (revenues, profit last 5 years)
14.1.5     Recent Contract(s) Won
14.1.6     Recent Projects Completed
14.1.7     Strategic Alliances
14.1.8     SWOT Analysis
14.2      Sanofi
14.2.1     Company Profile
14.2.2     Products & Services
14.2.3     Segment Revenue
14.2.4     Financial info (revenues, profit last 5 years)
14.2.5     Recent Contract(s) Won
14.2.6     Recent Projects Completed
14.2.7     Strategic Alliances
14.2.8     SWOT Analysis
14.3      GlaxoSmithKline (GSK)
14.3.1     Company Profile
14.3.2     Products & Services
14.3.3     Segment Revenue
14.3.4     Financial info (revenues, profit last 5 years)
14.3.5     Recent Contract(s) Won
14.3.6     Recent Projects Completed
14.3.7     Strategic Alliances
14.3.8     SWOT Analysis
14.4      Johnson & Johnson
14.4.1     Company Profile
14.4.2     Products & Services
14.4.3     Segment Revenue
14.4.4     Financial info (revenues, profit last 5 years)
14.4.5     Recent Contract(s) Won
14.4.6     Strategic Alliances
14.4.7     SWOT Analysis
14.5      Merck & Co.
14.5.1     Company Profile
14.5.2     Products & Services
14.5.3     Financial info (revenues, profit last 5 years)
14.5.4     Recent Contract(s) Won
14.5.5     Strategic Alliances
14.5.6     SWOT Analysis
14.6      Novavax
14.6.1     Company Profile
14.6.2     Products & Services
14.6.3     Financial info (revenues, profit last 5 years)
14.6.4     Recent Contract(s) Won
14.6.5     Strategic Alliances
14.6.6     SWOT Analysis
14.7      CSL Limited
14.7.1     Company Profile
14.7.2     Products & Services
14.7.3     Financial info (revenues, profit last 5 years)
14.7.4     Recent Contract(s) Won
14.7.5     Strategic Alliances
14.7.6     SWOT Analysis
14.8      AstraZeneca
14.8.1     Company Profile
14.8.2     Products & Services
14.8.3     Financial info (revenues, profit last 5 years)
14.8.4     Recent Contract(s) Won
14.8.5     Strategic Alliances
14.8.6     SWOT Analysis
14.9      Inovio Pharmaceuticals
14.9.1     Company Profile
14.9.2     Products & Services
14.9.3     Financial info (revenues, profit last 5 years)
14.9.4     Recent Contract(s) Won
14.9.5     Strategic Alliances
14.9.6     SWOT Analysis
14.10   Emergent BioSolutions
14.10.1  Company Profile
14.10.2  Products & Services
14.10.3  Financial info (revenues, profit last 5 years)
14.10.4  Recent Contract(s) Won
14.10.5  Strategic Alliances
14.10.6  SWOT Analysis

15     Strategic Conclusions

16     Appendices
16.1      Companies Mentioned
16.2      Abbreviations

17     About Market Info Group
17.1      General
17.2      Contact us